| Three multicenter, randomized, double‐blind, placebo‐controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis A Deodhar, LS Gensler, J Sieper, M Clark, C Calderon, Y Wang, Y Zhou, ... Arthritis & Rheumatology 71 (2), 258-270, 2019 | 335 | 2019 |
| Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis DR Jadon, R Sengupta, A Nightingale, M Lindsay, E Korendowych, ... Annals of the Rheumatic Diseases 76 (4), 701-707, 2017 | 236 | 2017 |
| Delay to diagnosis in axial spondyloarthritis: are we improving in the UK? MP Sykes, H Doll, R Sengupta, K Gaffney Rheumatology 54 (12), 2283-2284, 2015 | 133 | 2015 |
| Clinical utility of random anti–tumor necrosis factor drug–level testing and measurement of antidrug antibodies on the long‐term treatment response in rheumatoid arthritis M Jani, H Chinoy, RB Warren, CEM Griffiths, D Plant, B Fu, AW Morgan, ... Arthritis & rheumatology 67 (8), 2011-2019, 2015 | 118 | 2015 |
| Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration MA Stone, E Pomeroy, A Keat, R Sengupta, S Hickey, P Dieppe, ... Rheumatology 47 (8), 1213-1218, 2008 | 77 | 2008 |
| The assessment of ankylosing spondylitis in clinical practice R Sengupta, MA Stone Nature clinical practice Rheumatology 3 (9), 496-503, 2007 | 77 | 2007 |
| Prevalence and factors associated with disturbed sleep in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review S Leverment, E Clarke, A Wadeley, R Sengupta Rheumatology international 37, 257-271, 2017 | 74 | 2017 |
| Non-radiographic axial spondyloarthritis (nr-axSpA): advances in classification, imaging and therapy PC Robinson, R Sengupta, S Siebert Rheumatology and therapy 6, 165-177, 2019 | 72 | 2019 |
| Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy DR Jadon, AL Nightingale, NJ McHugh, MA Lindsay, E Korendowych, ... The Journal of rheumatology 42 (1), 21-30, 2015 | 69 | 2015 |
| Axial spondyloarthritis 10 years on: still looking for the lost tribe R Barnett, T Ingram, R Sengupta Rheumatology 59 (Supplement_4), iv25-iv37, 2020 | 59 | 2020 |
| Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis D Jadon, W Tillett, D Wallis, C Cavill, J Bowes, N Waldron, A Dixon, ... Rheumatology 52 (2), 261-266, 2013 | 59 | 2013 |
| Recommendations for acquisition and interpretation of MRI of the spine and sacroiliac joints in the diagnosis of axial spondyloarthritis in the UK TJP Bray, A Jones, AN Bennett, PG Conaghan, A Grainger, R Hodgson, ... Rheumatology 58 (10), 1831-1838, 2019 | 58 | 2019 |
| Juvenile versus adult-onset ankylosing spondylitis—clinical, radiographic, and social outcomes. A systematic review DR Jadon, AV Ramanan, R Sengupta The Journal of rheumatology 40 (11), 1797-1805, 2013 | 58 | 2013 |
| BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics L Hamilton, N Barkham, A Bhalla, R Brittain, D Cook, G Jones, K Mackay, ... Rheumatology 56 (2), 313-316, 2017 | 57 | 2017 |
| Fatigue contributes to work productivity impairment in patients with axial spondyloarthritis: a cross-sectional UK study S Espahbodi, P Bassett, C Cavill, M Freeth, J Hole, R Sengupta Clin Exp Rheumatol 35 (4), 571-578, 2017 | 51 | 2017 |
| Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study DR Jadon, R Sengupta, A Nightingale, H Lu, J Dunphy, A Green, JT Elder, ... Arthritis Research & Therapy 19, 1-10, 2017 | 48 | 2017 |
| Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register GJ Macfarlane, RIR MacDonald, E Pathan, S Siebert, K Gaffney, E Choy, ... Rheumatology 57 (11), 1982-1990, 2018 | 45 | 2018 |
| Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5 F Huang, F Sun, WG Wan, LJ Wu, LL Dong, X Zhang, TH Kim, ... Chinese Medical Journal 133 (21), 2521-2531, 2020 | 42 | 2020 |
| Increased risk of hypertension associated with spondyloarthritis disease duration: results from the ASAS-COMOSPA study MH Derakhshan, NJ Goodson, JC Packham, R Sengupta, A Molto, ... The Journal of rheumatology 46 (7), 701-709, 2019 | 40 | 2019 |
| Biologics for treating axial spondyloarthritis A Jones, C Ciurtin, M Ismajli, M Leandro, R Sengupta, PM Machado Expert Opinion on Biological Therapy 18 (6), 641-652, 2018 | 40 | 2018 |
Karl Gaffneyconultant Rheumatologist & Honorary Professor, Norwichยืนยันอีเมลแล้วที่ nnuh.nhs.uk